Acetylation writer inhibitor development and uses thereof
US12428412B2 · kind B2 · utility
0Cited by
0References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 2019 |
| Grant date | Sep 30, 2025 |
| Priority date | — |
| Expiry date | Apr 29, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N15/09
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are bifunctional compounds (degraders) that target HAT EP300 for degradation. Also disclosed are pharmaceutical compositions containing the degraders and methods of using the compounds to treat disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.